REFERENCES

[1] L. Guo, D. Wei, X. Zhang, Y. Wu, Q. Li, M. Zhou, J. Qu, Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score, Frontiers in Microbiology 10(2752) (2019).
[2] D.M. Musher, M.S. Abers, J.G. Bartlett, Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 65(10) (2017) 1736-1744.
[3] F.W. Arnold, J.L. Fuqua, Viral respiratory infections: a cause of community-acquired pneumonia or a predisposing factor?, Current opinion in pulmonary medicine (2020).
[4] F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song, X. Gu, L. Guan, Y. Wei, H. Li, X. Wu, J. Xu, S. Tu, Y. Zhang, H. Chen, B. Cao, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet (London, England) (2020).
[5] R.J. Tao, X.L. Luo, W. Xu, B. Mao, R.X. Dai, C.W. Li, L. Yu, F. Gu, S. Liang, H.W. Lu, K.B. Chen, J.W. Bai, X.B. Ji, S.Y. Gu, X.L. Sun, F.H. Dai, P. Jiang, W.J. Cao, J.F. Xu, Viral infection in community acquired pneumonia patients with fever: a prospective observational study, Journal of thoracic disease 10(7) (2018) 4387-4395.
[6] J.A. McCullers, The co-pathogenesis of influenza viruses with bacteria in the lung, Nature reviews. Microbiology 12(4) (2014) 252-62.
[7] D.M. Morens, J.K. Taubenberger, A.S. Fauci, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness, The Journal of infectious diseases 198(7) (2008) 962-70.
[8] S.P. Jochems, F. Marcon, B.F. Carniel, M. Holloway, E. Mitsi, E. Smith, J.F. Gritzfeld, C. Solorzano, J. Reine, S. Pojar, E. Nikolaou, E.L. German, A. Hyder-Wright, H. Hill, C. Hales, W.A.A. de Steenhuijsen Piters, D. Bogaert, H. Adler, S. Zaidi, V. Connor, S.B. Gordon, J. Rylance, H.I. Nakaya, D.M. Ferreira, Inflammation induced by influenza virus impairs human innate immune control of pneumococcus, Nature immunology 19(12) (2018) 1299-1308.
[9] A. Rynda-Apple, K.M. Robinson, J.F. Alcorn, Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease, Infection and immunity 83(10) (2015) 3764-70.
[10] F. Zhou, H. Li, L. Gu, M. Liu, C.X. Xue, B. Cao, C. Wang, Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients, Respiratory medicine 134 (2018) 86-91.
[11] Y.H. Ku, K.S. Chan, C.C. Yang, C.K. Tan, Y.C. Chuang, W.L. Yu, Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections, Journal of the Formosan Medical Association = Taiwan yi zhi 116(9) (2017) 660-670.
[12] L. Xu, B. Chen, F. Wang, C. Wei, H. Liu, J. Liu, F.J.F. Herth, F. Luo, A Higher Rate of Pulmonary Fungal Infection in Chronic Obstructive Pulmonary Disease Patients with Influenza in a Large Tertiary Hospital, Respiration; international review of thoracic diseases 98(5) (2019) 391-400.
[13] P. Zou, C. Wang, S. Zheng, F. Guo, L. Yang, Y. Zhang, P. Liu, Y. Shen, Y. Wang, X. Zhang, L. Tang, H. Gao, L. Li, Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study, The Journal of infectious diseases 221(Supplement_2) (2020) S193-s197.
[14] I. Martin-Loeches, J.S. M, J.L. Vincent, F. Alvarez-Lerma, L.D. Bos, J. Sole-Violan, A. Torres, A. Rodriguez, Increased incidence of co-infection in critically ill patients with influenza, Intensive care medicine 43(1) (2017) 48-58.
[15] A.R. Falsey, K.L. Becker, A.J. Swinburne, E.S. Nylen, M.A. Formica, P.A. Hennessey, M.M. Criddle, D.R. Peterson, A. Baran, E.E. Walsh, Bacterial complications of respiratory tract viral illness: a comprehensive evaluation, The Journal of infectious diseases 208(3) (2013) 432-41.
[16] G. Abelenda-Alonso, A. Rombauts, C. Gudiol, Y. Meije, L. Ortega, M. Clemente, C. Ardanuy, J. Niubó, J. Carratalà, Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes, Open forum infectious diseases 7(3) (2020) ofaa066.
[17] M.P. Crotty, S. Meyers, N. Hampton, S. Bledsoe, D.J. Ritchie, R.S. Buller, G.A. Storch, S.T. Micek, M.H. Kollef, Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study, Medicine 94(50) (2015) e2332.
[18] F. Zhou, Y. Wang, Y. Liu, X. Liu, L. Gu, X. Zhang, Z. Pu, G. Yang, B. Liu, Q. Nie, B. Xue, J. Feng, Q. Guo, J. Liu, H. Fan, J. Chen, Y. Zhang, Z. Xu, M. Pang, Y. Chen, X. Nie, Z. Cai, J. Xu, K. Peng, X. Li, P. Xiang, Z. Zhang, S. Jiang, X. Su, J. Zhang, Y. Li, X. Jin, R. Jiang, J. Dong, Y. Song, H. Zhou, C. Wang, B. Cao, Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network, The European respiratory journal 54(2) (2019).
[19] R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, S.M. Opal, J.E. Sevransky, C.L. Sprung, I.S. Douglas, R. Jaeschke, T.M. Osborn, M.E. Nunnally, S.R. Townsend, K. Reinhart, R.M. Kleinpell, D.C. Angus, C.S. Deutschman, F.R. Machado, G.D. Rubenfeld, S. Webb, R.J. Beale, J.L. Vincent, R. Moreno, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012, Intensive care medicine 39(2) (2013) 165-228.
[20] K.T. Shiley, E. Lautenbach, I. Lee, The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?, Infection control and hospital epidemiology 31(11) (2010) 1177-83.
[21] J. Dunning, R.S. Thwaites, P.J.M. Openshaw, Seasonal and pandemic influenza: 100 years of progress, still much to learn, Mucosal immunology (2020) 1-8.
[22] C. Ding, Y. Zhang, Z. Yang, J. Wang, A. Jin, W. Wang, R. Chen, S. Zhan, Incidence, temporal trend and factors associated with ventilator-associated pneumonia in mainland China: a systematic review and meta-analysis, BMC infectious diseases 17(1) (2017) 468.
[23] L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, N.C. Dean, S.F. Dowell, T.M. File, Jr., D.M. Musher, M.S. Niederman, A. Torres, C.G. Whitney, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 44 Suppl 2 (2007) S27-72.
[24] X. Li, B. Chen, S. Zhang, X. Li, J. Chang, Y. Tang, Y. Wu, X. Lu, Rapid Detection of Respiratory Pathogens for Community-Acquired Pneumonia by Capillary Electrophoresis-Based Multiplex PCR, SLAS TECHNOLOGY: Translating Life Sciences Innovation 24(1) (2019) 105-116.
[25] S. Jain, W.H. Self, R.G. Wunderink, S. Fakhran, R. Balk, A.M. Bramley, C. Reed, C.G. Grijalva, E.J. Anderson, D.M. Courtney, J.D. Chappell, C. Qi, E.M. Hart, F. Carroll, C. Trabue, H.K. Donnelly, D.J. Williams, Y. Zhu, S.R. Arnold, K. Ampofo, G.W. Waterer, M. Levine, S. Lindstrom, J.M. Winchell, J.M. Katz, D. Erdman, E. Schneider, L.A. Hicks, J.A. McCullers, A.T. Pavia, K.M. Edwards, L. Finelli, Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults, The New England journal of medicine 373(5) (2015) 415-27.
[26] M.P. Nicol, L. Workman, W. Isaacs, J. Munro, F. Black, B. Eley, C.C. Boehme, W. Zemanay, H.J. Zar, Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study, The Lancet. Infectious diseases 11(11) (2011) 819-24.
[27] J.M. Miller, M.J. Binnicker, S. Campbell, K.C. Carroll, K.C. Chapin, P.H. Gilligan, M.D. Gonzalez, R.C. Jerris, S.C. Kehl, R. Patel, B.S. Pritt, S.S. Richter, B. Robinson-Dunn, J.D. Schwartzman, J.W. Snyder, S. Telford, 3rd, E.S. Theel, R.B. Thomson, Jr., M.P. Weinstein, J.D. Yao, A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 67(6) (2018) 813-816.
[28] J.P. Donnelly, S.C. Chen, C.A. Kauffman, W.J. Steinbach, J.W. Baddley, P.E. Verweij, C.J. Clancy, J.R. Wingard, S.R. Lockhart, A.H. Groll, T.C. Sorrell, M. Bassetti, H. Akan, B.D. Alexander, D. Andes, E. Azoulay, R. Bialek, R.W. Bradsher, S. Bretagne, T. Calandra, A.M. Caliendo, E. Castagnola, M. Cruciani, M. Cuenca-Estrella, C.F. Decker, S.R. Desai, B. Fisher, T. Harrison, C.P. Heussel, H.E. Jensen, C.C. Kibbler, D.P. Kontoyiannis, B.J. Kullberg, K. Lagrou, F. Lamoth, T. Lehrnbecher, J. Loeffler, O. Lortholary, J. Maertens, O. Marchetti, K.A. Marr, H. Masur, J.F. Meis, C.O. Morrisey, M. Nucci, L. Ostrosky-Zeichner, L. Pagano, T.F. Patterson, J.R. Perfect, Z. Racil, E. Roilides, M. Ruhnke, C.S. Prokop, S. Shoham, M.A. Slavin, D.A. Stevens, G.R. Thompson, J.A. Vazquez, C. Viscoli, T.J. Walsh, A. Warris, L.J. Wheat, P.L. White, T.E. Zaoutis, P.G. Pappas, Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2019).
[29] V.M. Ranieri, G.D. Rubenfeld, B.T. Thompson, N.D. Ferguson, E. Caldwell, E. Fan, L. Camporota, A.S. Slutsky, Acute respiratory distress syndrome: the Berlin Definition, Jama 307(23) (2012) 2526-33.
[30] W.S. Lim, S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson, I. Le Jeune, J.T. Macfarlane, R.C. Read, H.J. Roberts, M.L. Levy, M. Wani, M.A. Woodhead, BTS guidelines for the management of community acquired pneumonia in adults: update 2009, Thorax 64 Suppl 3 (2009) iii1-55.
[31] M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, D.E. Singer, C.M. Coley, T.J. Marrie, W.N. Kapoor, A prediction rule to identify low-risk patients with community-acquired pneumonia, The New England journal of medicine 336(4) (1997) 243-50.
[32] J.X. Qu, L. Gu, Z.H. Pu, X.M. Yu, Y.M. Liu, R. Li, Y.M. Wang, B. Cao, C. Wang, Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity, BMC infectious diseases 15 (2015) 89.
[33] C.L. Charlton, E. Babady, C.C. Ginocchio, T.F. Hatchette, R.C. Jerris, Y. Li, M. Loeffelholz, Y.S. McCarter, M.B. Miller, S. Novak-Weekley, Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections, Clinical microbiology reviews 32(1) (2018) e00042-18.
[34] Y. Zhan, Z. Yang, R. Chen, Y. Wang, W. Guan, S. Zhao, Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls, BMC Pulm Med 14 (2014) 144.
[35] R. Gilca, R. Amini, M. Douville-Fradet, H. Charest, J. Dubuque, N. Boulianne, D.M. Skowronski, G. De Serres, Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season, Open forum infectious diseases 1(2) (2014) ofu086.
[36] C.-C.L. a, C.-Y.W. b, P.-R.H. c, Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents?, Journal of Microbiology, Immunology and Infection (2020).
[37] I. Martin-Loeches, F. van Someren Gréve, M.J. Schultz, Bacterial pneumonia as an influenza complication, Curr Opin Infect Dis 30(2) (2017) 201-207.
[38] R.K. Leung, J.W. Zhou, W. Guan, S.K. Li, Z.F. Yang, S.K. Tsui, Modulation of potential respiratory pathogens by pH1N1 viral infection, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 19(10) (2013) 930-5.
[39] S. Edouard, M. Million, D. Bachar, G. Dubourg, C. Michelle, L. Ninove, R. Charrel, D. Raoult, The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens, European Journal of Clinical Microbiology & Infectious Diseases 37(9) (2018) 1725-1733.
[40] T. Qin, T. Geng, H. Zhou, Y. Han, H. Ren, Z. Qiu, X. Nie, T. Du, J. Liang, P. Du, W. Jiang, T. Li, J. Xu, Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota as causative agents of secondary bacterial infection in influenza patients, Emerging microbes & infections 9(1) (2020) 605-615.
[41] J.L. Vincent, Y. Sakr, M. Singer, I. Martin-Loeches, F.R. Machado, J.C. Marshall, S. Finfer, P. Pelosi, L. Brazzi, D. Aditianingsih, J.F. Timsit, B. Du, X. Wittebole, J. Máca, S. Kannan, L.A. Gorordo-Delsol, J.J. De Waele, Y. Mehta, M.J.M. Bonten, A.K. Khanna, M. Kollef, M. Human, D.C. Angus, Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017, Jama (2020).
[42] J.A. Jernigan, K.M. Hatfield, H. Wolford, R.E. Nelson, B. Olubajo, S.C. Reddy, N. McCarthy, P. Paul, L.C. McDonald, A. Kallen, A. Fiore, M. Craig, J. Baggs, Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017, New England Journal of Medicine 382(14) (2020) 1309-1319.
[43] M.F. Di Pasquale, G. Sotgiu, A. Gramegna, D. Radovanovic, S. Terraneo, L.F. Reyes, J. Rupp, J. González Del Castillo, F. Blasi, S. Aliberti, M.I. Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 68(9) (2019) 1482-1493.
[44] K. Sun, D.W. Metzger, Influenza Infection Suppresses NADPH Oxidase–Dependent Phagocytic Bacterial Clearance and Enhances Susceptibility to Secondary Methicillin-Resistant <em>Staphylococcus aureus</em> Infection, The Journal of Immunology 192(7) (2014) 3301-3307.
[45] G. Voiriot, B. Visseaux, J. Cohen, L.B.L. Nguyen, M. Neuville, C. Morbieu, C. Burdet, A. Radjou, F.-X. Lescure, R. Smonig, L. Armand-Lefèvre, B. Mourvillier, Y. Yazdanpanah, J.-F. Soubirou, S. Ruckly, N. Houhou-Fidouh, J.-F. Timsit, Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia, Critical Care 20(1) (2016) 375.
[46] L.O. Bakaletz, Viral-bacterial co-infections in the respiratory tract, Current opinion in microbiology 35 (2017) 30-35.
[47] B.S. Bender, T. Croghan, L. Zhang, P.A. Small, Jr, Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge, Journal of Experimental Medicine 175(4) (1992) 1143-1145.
[48] R.M. Koch, M. Kox, M.I. de Jonge, J.G. van der Hoeven, G. Ferwerda, P. Pickkers, Patterns in Bacterial- and Viral-Induced Immunosuppression and Secondary Infections in the ICU, Shock (Augusta, Ga.) 47(1) (2017) 5-12.
[49] R. Pfister, M. Kochanek, T. Leygeber, C. Brun-Buisson, E. Cuquemelle, M.B. Machado, E. Piacentini, N.E. Hammond, P.R. Ingram, G. Michels, Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis, Critical care (London, England) 18(2) (2014) R44.
[50] C.-E. Luyt, T.W. Rice, Co-infection in severe influenza: a new epidemiology?, Intensive care medicine 43(1) (2017) 107-109.
[51] A.M. Walker, H. Jick, J. Porter, Drug-Related Superinfection in Hospitalized Patients, Jama 242(12) (1979) 1273-1275.
[52] K. Chen, J.K. Kolls, T cell-mediated host immune defenses in the lung, Annual review of immunology 31 (2013) 605-33.
[53] L.J. Quinton, A.J. Walkey, J.P. Mizgerd, Integrative Physiology of Pneumonia, Physiological reviews 98(3) (2018) 1417-1464.